213 filings
Page 8 of 11
8-K
ne0ck
20 Dec 18
Departure of Directors or Certain Officers
4:02pm
8-K
dsz1lw12oa 3pwu
8 Nov 18
Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results
4:05pm
8-K
j18b8jz
1 Nov 18
Departure of Directors or Certain Officers
4:01pm
8-K
ist4y fh4
16 Oct 18
Other Events
9:00am
8-K
4ilem
11 Oct 18
Kala Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:11pm
CT ORDER
w8iuc9b
9 Oct 18
Confidential treatment order
12:00am
8-K
2f78b1q7
5 Oct 18
Kala Pharmaceuticals Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock
6:01am
424B2
5ob77ip ufst0l6kgb81
3 Oct 18
Prospectus for primary offering
5:26pm
424B2
5vbjvb60rqkysgdjo
2 Oct 18
Prospectus for primary offering
5:26pm
8-K
foi52nfv7prjrxj8h
2 Oct 18
Other Events
4:40pm
8-K
v5po8
2 Oct 18
Kala Pharmaceuticals Announces Financing from Athyrium Capital Management Totaling $110 Million
4:38pm
8-K
ojceu hg80vgu2
5 Sep 18
Regulation FD Disclosure
12:00am
EFFECT
ql2xpgaa
27 Aug 18
Notice of effectiveness
12:00am
CORRESP
dhag87sqmd1
23 Aug 18
Correspondence with SEC
12:00am
8-K
gw855z
23 Aug 18
Kala Pharmaceuticals Announces FDA Approval of INVELTYSTMÂ for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
12:00am
CT ORDER
nkigvtt0za3 shjaa
22 Aug 18
Confidential treatment order
12:00am
CORRESP
l3xljymb
20 Aug 18
Correspondence with SEC
12:00am
S-3/A
tgp5hizmth396r6eg0s
20 Aug 18
Shelf registration (amended)
12:00am
8-K
ogripb
15 Aug 18
Regulation FD Disclosure
8:00am